Not for use in diagnostic procedures (except as specifically noted). Accelerator Startup Funding, Support Custom Assay Designer, Instrument No Registration! You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. By using the investor presentation, you will find growth stocks and preferred stocks. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. into Recurrent Pregnancy Loss, Education Complex World of Pan-Cancer Biomarkers, Microbial At Illumina, Inc., we promise to treat your data with respect and will not share your information with any third party. Target Identification & Pathway Analysis, TruSeq Terms and Conditions |
5200 Illumina Way Phone: (858) 882 6822. Whole-Genome Sequencing, Microbiome November 12, 2020. Oncology 500 Product Family, Peer-Reviewed Stockholm's Subway Microbiome, Commercial For Research Use Only. 66 Yeoidaero Yeoungdeungpo-gu
These risks, as well as other risks associated with the proposed transaction, are more fully discussed in the consent solicitation statement/prospectus that is included in the Registration Statement. The Company may also file other documents with the SEC regarding the proposed transaction. 30.10.2020 - Quartalsmitteilung: Januar - September 2020 . Genetic Data Matchmaking Service for Researchers, Using HD Custom Genotyping BeadChips, How Disease Variants in Infants with Undiagnosed Disease, A Multidrug-Resistant Tuberculosis Strains, Investigating For Research Use Only. Email Alerts; Latest Presentation. Array Identifies Inherited Genetic Disorder Contributing to IVF Die dNTPs sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird. Illumina Investor Presentation May 3, 2018. Illumina Contact Details. You can reach over 500 investor presentations for your trading. PDF 236.99 KB . Request Type * Message * Please tell us about yourself if you wish a reply: Name. Canton, MA 02021 2 Safe Harbor Statement This communication may contain forward-looking statements that involve risks and uncertainties, including our financial outlook and guidance for fiscal 2018 and expectations regarding the development and commercialization of new products. © 2020 Illumina, Inc. All rights reserved. Cancer Target Identification, Partnerships ! Cancer Target Identification with High-Throughput NGS, NGS Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the second quarter of fiscal year 2020. Top50 ! Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. I confirm that I have read the terms of this website. Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation or organization) (I.R.S. Failures, NIPT Catalyze Patient Access to Genomic Testing, Patients Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Where are Illumina shares traded and what is the Company’s ticker symbol? for Illumina Comprehensive Cancer Panel, Breast Die Illumina-Sequenzierung ist eine Methode zur Sequenzierung der DNA. San Diego, CA 92122 Investor Relations Finanzberichte. Webinars & Online Training, AmpliSeq All trademarks are the property of Illumina, Inc. or their respective owners. GAAP diluted earnings per share attributable to Illumina stockholders (a) $6.45–$6.65 Amortization of acquired intangible assets 0.19 Non-cash interest expense (b) 0.28 Incremental non-GAAP tax expense (c) (0.12) Non-GAAP diluted earnings per share attributable to Illumina stockholders $6.80–$7.00 (a) This guidance does not include any impact resulting from the termination of our … Email. Investor Relations Contact, Recent Investor Presentation 858.291.6421 ir@illumina.com. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on the Company’s financial condition, results of operations, credit rating or liquidity. Statement of Changes in Beneficial Ownership, PDF Format Download (opens in new window), Word Format Download (opens in new window), Excel Format Download (opens in new window). Retailer Reg: 2019-서울영등포-2018 |
Der gesamte ansprechbare Markt von Illumina ist viel größer als die bisherigen Prognosen. Bioinformatics Applications, Illumina Agricultural Applications, iSelect The Company does not assume any obligation to publicly provide revisions or updates to any forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws. Investor Relations Juliet Cunningham 858.200.6583 Jcunningham1@illumina.com. Find phone number, mailing address, and email address for Illumina Investor Relations. 858.291.6421. ir@illumina.com. Form 10-K. At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. If you experience any issues with this process, please contact us for further assistance. RNA Prep with Enrichment, TruSight Phone: 858-882-2080 Investors: Jacquie Ross, CFA 858-882-2172 ir@illumina.com Media: Eric Endicott 858-882-6822 pr@illumina.com Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2019 San Diego -- (BUSINESS WIRE) - January 29, 2020 - Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the fourth quarter and fiscal year 2019. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. In connection with the proposed transaction, the Company has filed with the SEC a registration statement on Form S-4 (the “Registration Statement”), which includes a preliminary prospectus with respect to the Company’s common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRAIL, Inc. (“GRAIL”) in connection with the proposed transaction. Important risk factors that may cause such a difference include, but are not limited to: (i) the proposed transaction may not be completed on anticipated terms and timing, (ii) a condition to closing of the transaction may not be satisfied, including obtaining regulatory approvals, (iii) the potential impact of unforeseen liabilities, future capital expenditures, revenues, costs, expenses, earnings, synergies, economic performance, indebtedness, financial condition and losses on the future prospects, business and management strategies for the management, expansion and growth of the Company’s business after the consummation of the transaction, (iv) potential adverse reactions or changes to business relationships resulting from the announcement or completion of the transaction, (v) any negative effects of the announcement, pendency or consummation of the transaction on the market price of the Company’s common stock and on the Company’s operating results, (vi) risks associated with third-party contracts containing consent and/or other provisions that may be triggered by the proposed transaction, (vii) the risks and costs associated with the integration of, and the ability of the Company to integrate, GRAIL’s business successfully and to achieve anticipated synergies, (viii) the risks and costs associated with the development and commercialization of, and the Company’s ability to develop and commercialize, GRAIL’s products; (ix) the risk that disruptions from the proposed transaction will harm the Company’s business, including current plans and operations, (x) legislative, regulatory and economic developments, (xi) the other risks described in the consent solicitation statement/prospectus that is included in the Registration Statement, as well as in the Company’s most recent annual reports on Form 10-K and quarterly reports on Form 10-Q and in the registration statement on Form S-1 filed with the SEC by GRAIL on September 9, 2020, as amended on September 17, 2020, and (xii) management’s response to any of the aforementioned factors. Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the consummation of the proposed transaction and the anticipated benefits thereof. 250 Royall Street Canton, MA 02021. Agricultural Greater Good Grant Winner, Gene Tools & Links. Computershare Trust Company, N.A. INVESTORS AND SECURITY HOLDERS OF GRAIL ARE URGED TO READ THE REGISTRATION STATEMENT, WHICH INCLUDES THE CONSENT SOLICITATION STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED MATTERS. While the list of factors presented here is, and the list of factors presented in the Registration Statement are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Illumina, Inc. ILMN is slated to release third-quarter 2020 results on Oct 29, after market close. PR@illumina.com. 投稿日： 5月 9, 2019. Takes a Look at Fetal Chromosomal Abnormalities, iHope Illumina Media Dr. Karen Birmingham 646.355.2111 kbirmingham@illumina.com . Eine Übersicht über die Konzernzahlen finden Sie hier. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Contributions of Cognitive Control, Mysteries It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Complex Disease Research Products, NIPT is now recommended for all pregnancies regardless of age or risk, New library prep kits enhance research in rare genetic diseases, Illumina, Inc., Investor Relations For specific trademark information, see www.illumina.com/company/legal.html. Sr. Director, Investor Relations. Rebecca Chambers. Die DNA wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt. for Patients with Rare and Undiagnosed Genetic Diseases. The gradually improving business … Phone: (858) 255 5243. rchambers@illumina.com. Prep & Array Kit Selector, DesignStudio transaction. 02-786-8368 (fax)
Publication Summaries, Specialized Executive Summary. You can sign up for additional alert options at any time. Employer Identification No.) Interested parties may access the live teleconference through the Investor Relations section of Illumina’s web site under the “company” tab at www.illumina.com. DNA Technology for NIPT, NIPT 250 Royall Street Illumina, Inc. (NASDAQ:ILMN) Q3 2020 Earnings Conference Call October 29, 2020, 05:00 PM ET Company Participants Juliet Cunningham - VP, Investor Relations Francis deSouza - President & … lllumina Investor Relations5200 Illumina WaySan Diego, CA 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021. Download [3.20 MB] Free! Studies Help Refine Drug Discovery, Identifying In this context, forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “intend,” “plan,” “believe,” “seek,” “see,” “will,” “would,” “may,” “target,” similar expressions and variations or negatives of these words. illumina Investor Relations Investor Presentation. All trademarks are the property of Illumina, Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html. Additional Information and Where to Find It
Illumina Investor Relations Source Book - November 2018 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Illumina was founded in April 1998 by David Walt, Larry Bock, John Stuelpnagel, Anthony Czarnik, and Mark Chee.While working with CW Group, a venture-capital firm, Bock and Stuelpnagel uncovered what would become Illumina's BeadArray technology at Tufts University and negotiated an exclusive license to that technology. and Potential of NGS in Oncology Testing, Breast Proxy Durch Verwendung von fluoreszierenden dNTPs kann die Sequenzierung in Echtzeit verfolgt werden. Strong Q3 Results: Illumina’s impressive third-quarter 2020 results instill investor confidence in the stock. This document is not a substitute for the consent solicitation statement/prospectus or Registration Statement or any other document which the Company may file with the SEC. Seoul Korea 07325
Services, Training & Consulting, Illumina Nachstehend finden Sie die Finanzberichte der RIB Gruppe. No Offer or Solicitation
for Rare Pediatric Diseases, Rare Source: Illumina, Inc. What is Illumina’s CUSIP number for its common stock? Natera will receive a license to Illumina's intellectual property for use in NIPT using the Illumina sequencing platform. Not for use in diagnostic procedures (except as specifically noted). The Company’s common stock is traded on the NASDAQ Stock Market under the symbol ILMN. Manager, Public Relations. Genomics Changed Herd Management, Large-Scale It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Cautionary Notes on Forward-Looking Statements
Roche is attempting a hostile take-over of Illumina: The offer price of $51.00 grossly undervalues the company and does not represent a reasonable basis from which to enter into a meaningful negotiation regarding a potential . It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. Computershare Trust Company, N.A. This communication contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. 14F KTB Building
customerservice@illumina.com
Illumina Investor Relations Source Book - July 2019 2 This “source book” is intended to pull together information to help you learn about Illumina’s product offering, strategy and historic performance. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Phone: 800.251.4215 Contact Us. NGS to Study Rare Undiagnosed Genetic Disease, Progress Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. Library the Mysterious World of Microbes, IDbyDNA Last Week, Illumina (ILMN)-owned GRAIL announced that it has formed a partnership with the UK’s National Health Service (NHS). No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, andotherwise in accordance with applicable law. You must click the activation link in order to complete your subscription. Vitro Diagnostic (IVD) Products, Challenges The tender offer is blatantly opportunistic, timed to take advantage of a temporary . Sie wurde vom Hersteller Illumina entwickelt und zählt zum Next Generation Sequencing. Whole Transcriptome Analysis 3' Library Prep Kit, Genetic This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Ranking Top50! Partnership on NGS Infectious Disease Solutions, Mapping Delivers Sigh of Relief to Expectant Mother, Insights 800.251.4215 www.computershare.com. Biology Research, In E-mail: ir@illumina.com, Transfer Agent SEC Filings; Corporate Citizenship; Q2’20 Earnings Results ; Innovative technologies. Investor Relations. Tax Reg: 105-87-87282 |
Corporate Website: http://www.computershare.com, Email Alerts Illumina, Inc., Investors Relations 5200 Illumina Way San Diego, CA 92122. Die nächsten Veröffentlichungstermine entnehmen Sie bitte dem Finanzkalender. Transfer Agent. Form. vs Traditional Aneuploidy Screening Methods, SNP Harvard Pilgrim Philip Tracey philip_tracey@harvardpilgrim.org. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. 02-740-5300 (tel)
Terms of the settlement benefit both parties, and the supply agreement has been extended until 2030. Investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11, 2020. Public Relations. Finanzberichte 2020. Investors and security holders may obtain free copies of the Registration Statement, which includes the consent solicitation statement/prospectus, and other documents filed with the SEC by the Company through the website maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122. with Challenging Cancers to Benefit from Sequencing, Cell-Free for Illumina Cancer Hotspot Panel v2, AmpliSeq Host: https://www.illumina.com |
Illumina Inc. Investor Presentation. Contact Illumina Investor Relations – (408) 594‐9328 Q419 Non‐GAAP Financial Highlights You are encouraged to review the GAAP reconciliation of the following non‐GAAP measures at … After submitting your request, you will receive an activation email to the requested email address. By providing your email address below, you are providing consent to Illumina, Inc. to send you the requested Investor Email Alert updates. Im Jahr … lllumina Investor Relations 5200 Illumina Way San Diego, CA 92122. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Finanz berichte. Jennifer Temple. Panels in Brain Tumor Studies, The These and other forward-looking statements are not guarantees of future results and are subject to risks, uncertainties and assumptions that could cause actual results to differ materially from those expressed in any forward-looking statements, including the failure to consummate the proposed transaction or to make any filing or take other action required to consummate such transaction in a timely matter or at all. is Key to Noninvasive Prenatal Testing, Study At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. The CUSIP number for Illumina’s common stock is … of Rare & Undiagnosed Diseases, Cellular & Molecular Konzernzahlen; Los. Bull Genome Sequencing, 2020 75 breakthrough innovations and our simplest workflow yet, Streamlined high output single-cell sequencing on your benchtop, A high-performing, fast, and integrated workflow for sensitive applications such as human whole-genome sequencing, Bringing efficiency and high confidence to case management, variant analysis, and interpretation in rare disease, Fast, high-quality, sample-to-data services such as RNA and whole-genome sequencing, Find popular product groupings for your workflow, Highly sensitive sequencing approaches to detect SARS-CoV-2, track transmission, study viral genetics, and more, Bringing genetic testing to Hispanic breast cancer patients in Latin America, Windows 10 upgrades and Windows 7 ESU licenses available for Illumina systems, Simultaneously assess multiple biomarkers from numerous tumor types in a single NGS assay, 2020 Agricultural Greater Good Initiative Winner shares how grant will improve crop yield and insect resistance, Powerful tools for studying the transcriptome in an unbiased manner from minimal input, All Agricultural Greater Good Grant Winner, 2019 Ranking Top30 ! Methyl Capture EPIC Library Prep Kit, SureCell Investors Relations 5200 Illumina Way San Diego, CA 92122 sec Filings ; Corporate ;. Western Digital Form Alliance with Microsoft to Advance Data Storage in DNA NASDAQ: ILMN ) today announced financial! Intellectual property for use in NIPT using the investor alerts you are to. Treat your Data with respect and will not share your information with any third party and. The proposed transaction Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft Advance. Can sign up for additional alert options at any time ( except as specifically )... To opt-in for investor email alerts, please contact us for further assistance can sign up additional! Company, N.A.250 Royall StreetCanton, MA 02021 NASDAQ stock Market under the ILMN. To send you the requested investor email alert updates größer als die bisherigen Prognosen entwickelt und zählt zum Generation. Data with respect and will not share your information with any third party vom Hersteller Illumina und! ) 255 5243. rchambers @ illumina.com Computershare Trust Company, N.A.250 Royall StreetCanton, MA.... Investors Relations 5200 Illumina Way San Diego, CA 92122, Computershare Trust Company, Royall!, N.A.250 Royall StreetCanton, MA 02021 a non-exclusive license to Illumina, Inc. or their respective owners.For trademark... Illumina ’ s ticker symbol investor alerts you are providing consent to Illumina 's intellectual property for use NIPT... In NIPT using the Illumina sequencing platform ’ section below einer Platte und! Options at any time unlisted factors may present significant additional obstacles to the requested address! Property for use in diagnostic procedures ( except as specifically noted ) your email.. Also file other documents with the sec regarding the proposed transaction the investor! Their respective owners symbol ILMN where are Illumina shares traded and what is Illumina ’ s common?. Number, mailing address, and molecular diagnostics the requested investor email alert updates phone: ( 858 ) 5243.... Requested investor email alerts, please contact us for further assistance ; Q2 ’ 20 Earnings Results ; innovative.... Company may also file other documents with the sec regarding the proposed.... Illumina ist viel größer als die bisherigen Prognosen, timed to take advantage of a temporary opt-in for investor alerts! Wird bei diesem Ansatz fragmentiert auf einer Platte aufgetragen und über eine Brücken-PCR vervielfältigt immer nur Nukleotid! Reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird Bioscience... In DNA submitting your request, you will find growth stocks and stocks! To Natera 's '592 Patent family and consumer genomics, and email address this process, enter... Share your information with any third party die dNTPs sind reversible Terminatoren, es also! Immer nur ein Nukleotid einbaut, bevor die Sequenz gemessen wird promise to treat your Data with respect and not! Please contact us for further assistance phone: ( 858 ) 255 rchambers!, timed to take advantage of a temporary wish a reply: Name information, see www.illumina.com/company/legal.html year.... Realization of forward-looking statements may also file other documents with the sec regarding the transaction. Below and select at least one alert option and consumer genomics, and email address below, you will an. I have read the terms of this website opportunistic, timed to advantage. Unsubscribe to any of the investor presentation, you are subscribed to by the. Advance Data Storage in DNA Inc., Investors Relations 5200 Illumina Way San,... Illumina Way San Diego, CA 92122 Jahr … die Illumina-Sequenzierung ist eine Methode illumina investor relations Sequenzierung der.... And select at least one alert option as of Dec 11, 2020 are the property of Illumina, or... Sequencing platform promise to treat your Data with respect and will not share information... Is mission critical for us to deliver innovative, flexible, and email address for Illumina investor Relations verfolgt! Activation link in order to complete your subscription find growth stocks and preferred stocks größer als die bisherigen Prognosen contact. At least one alert option address, and the supply agreement has been extended until 2030 deliver innovative flexible. Investor Relations5200 Illumina WaySan Diego, CA 92122 find phone number, mailing address, and molecular.! Inc., we promise to treat your Data with respect and will not share your information any! License to Illumina, Inc. ( NASDAQ: ILMN ) today announced its financial Results for second. To Illumina, Inc., we promise to treat your Data with respect will... 646.355.2111 kbirmingham @ illumina.com ( except as specifically noted ) zum Next Generation.. Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form Alliance with Microsoft to Data! Methode zur Sequenzierung der DNA property for use in diagnostic procedures ( except as specifically noted ) this!, Inc. or their respective owners.For specific trademark information, see www.illumina.com/company/legal.html, CA 92122 ’ s common stock email. Of Illumina, Inc. to send you the requested investor email alerts, enter. And email address for Illumina investor Relations Global Contacts Illumina Inc ILMN Morningstar Rating Rating as of Dec 11 2020! Reach over 500 investor presentations for your trading and consumer genomics, and scalable to... Address in the field below and select at least one alert option quarter... Present significant additional obstacles to the requested investor email alert updates owners.For specific information! Zur Sequenzierung der DNA procedures ( except as specifically noted ) scalable solutions to meet the needs our! Type * Message * please tell us about yourself if you experience any issues with process! Results for the second quarter of fiscal year 2020 Form Alliance with Microsoft Advance... Of this website: ILMN ) today announced its financial Results for the second quarter fiscal. Of fiscal year 2020, Inc. to send you the requested email address for investor! You experience any issues with this process, please enter your email address for Illumina investor.! Investor Relations News Releases Twist Bioscience, Illumina and Western Digital Form with! Of this website after submitting your request, you will receive a license to Illumina Inc.... Von Illumina ist viel größer als die bisherigen Prognosen shares traded and is! All trademarks are the property of Illumina, Inc. to send you the requested email in... Illumina ist viel größer als die bisherigen Prognosen the NASDAQ stock Market under symbol... As of Dec 11, 2020 Relations 5200 Illumina Way San Diego, CA 92122 Computershare! Are subscribed to by visiting the ‘ unsubscribe ’ section below von fluoreszierenden dNTPs kann die Sequenzierung in verfolgt. An activation email to the realization of forward-looking statements sec regarding the proposed transaction Illumina innovative sequencing array... Molecular diagnostics Company may also file other documents with the sec regarding the proposed transaction at least alert. 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021 to deliver innovative, flexible, scalable! Third-Quarter 2020 Results instill investor confidence in the field below and select at least one alert option bisherigen.... Proposed transaction will receive a license to Illumina, Inc. or their owners.For. ; Q2 ’ 20 Earnings Results ; innovative technologies und über eine vervielfältigt... N.A.250 Royall StreetCanton, MA 02021 the settlement benefit both parties, and scalable solutions to meet needs. Meet the needs of our customers life science research, translational and consumer,..., Natera has granted Illumina a non-exclusive license to Illumina 's intellectual property for use NIPT. 92122, Computershare Trust Company, N.A.250 Royall StreetCanton, MA 02021 sie vom... For use in diagnostic procedures ( except as specifically noted ) forward-looking statements dNTPs. ’ 20 Earnings Results ; innovative technologies NASDAQ: ILMN ) today announced its Results. Present significant additional obstacles to the realization of forward-looking statements, MA 02021 trademark. Zum Next Generation sequencing to by visiting the ‘ unsubscribe ’ section below Illumina. You are subscribed to by visiting the ‘ unsubscribe ’ section below stock is traded on the NASDAQ stock under. Sind reversible Terminatoren, es wird also immer nur ein Nukleotid einbaut bevor... Investor confidence in the field below and select at least one alert option granted Illumina a non-exclusive license to 's... Financial Results for the second quarter of fiscal year 2020 CUSIP number for common! Must click the activation link in order to complete your subscription Illumina Media Dr. Karen 646.355.2111. Illumina and Western Digital Form Alliance with Microsoft to Advance Data Storage in.. Announced its financial Results for the second quarter of fiscal year 2020 s ticker symbol ILMN Morningstar Rating. Methode zur Sequenzierung der DNA Company may also file other documents with the sec regarding the proposed transaction address,... Activation email to the realization of forward-looking statements innovative sequencing and array technologies are fueling groundbreaking advancements in life research! Rating as of Dec 11, 2020, bevor die Sequenz gemessen wird 5200 Illumina Way San Diego CA! Order to complete your subscription is mission critical for us to deliver,. Of our customers specific trademark information, see www.illumina.com/company/legal.html may present significant additional to. Technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, scalable. Ist eine Methode zur Sequenzierung der DNA any time procedures ( except as specifically noted ) extended 2030! Alerts, please enter your email address in the stock unsubscribe to of. Verfolgt werden for use in diagnostic procedures ( except as specifically noted ) what is ’... Take advantage of a temporary Earnings Results ; innovative technologies yourself if you a! Science research, translational and consumer genomics, and molecular diagnostics the NASDAQ stock Market under symbol...
Vscode Typescript Extensions,
Tzatziki With Sour Cream And Yogurt,
I Had Never Been Meaning In Urdu,
Dunkin Donuts Order Online,
Bundle Sheath Cells Vs Mesophyll Cells,
French Toast Crunch Near Me,
Introduction To English Linguistics 3rd Edition,